Show simple item record

dc.contributor.authorAmirsaadat, S
dc.contributor.authorPilehvar-Soltanahmadi, Y
dc.contributor.authorZarghami, F
dc.contributor.authorAlipour, S
dc.contributor.authorEbrahimnezhad, Z
dc.contributor.authorZarghami, N
dc.date.accessioned2018-08-26T07:21:21Z
dc.date.available2018-08-26T07:21:21Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/46097
dc.description.abstractNanoparticle-based targeted drug delivery has the potential for rendering silibinin specifically at the favorite site using an external magnetic field. Also, it can circumvent the pitfalls of poor solubility. For this purpose, silibinin-loaded magnetic nanoparticles are fabricated, characterized and evaluated cytotoxicity and hTERT gene expression in A549 lung cancer cell line. silibinin-loaded PLGA-PEG-Fe3O4 had dose- and time-dependent cytotoxicity than pure silibinin. Additionally, hTERT expression is more efficiently reduced with increasing concentrations of nanosilibinin than pure silibinin. The present study indicates that PLGA-PEG-Fe3O4 nanoparticles, as an effective targeted carrier, can make a promising horizon in targeted lung cancer therapy.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectSilibinin
dc.subject(FeO4)-O-3
dc.subjectPLGA-PEG
dc.subjectA549
dc.subjecthTERT
dc.titleSilibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells
dc.typeArticle
dc.citation.volume45
dc.citation.issue8
dc.citation.spage1649
dc.citation.epage1656
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1080/21691401.2016.1276922


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record